SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-000635
Filing Date
2019-01-15
Accepted
2019-01-15 06:02:33
Documents
4
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 6-K asln-6k_20190115.htm 6-K 19834
2 EX-99.1 asln-ex991_6.htm EX-99.1 16643
3 GRAPHIC glpcau5d3snl000001.jpg GRAPHIC 7142
4 GRAPHIC glpcau5d3snl000002.jpg GRAPHIC 7142
  Complete submission text file 0001564590-19-000635.txt   57507
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 19526113
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1